THE USE OF SMALL MOLECULE CYSTEINE PROTEASE INHIBITORS, E64D/E64C, FOR TRAUMATIC BRAIN INJURY DRUG DEVELOPMENT

被引：0

作者：

Hook, Greg ^{[1
]}

Jacobsen, Steven ^{[2
]}

Grabstein, Kenneth ^{[3
]}

Kindy, Mark ^{[4
]}

Hook, Vivian ^{[5
]}

机构：

[1] Amer Life Sci Pharmaceut, La Jolla, CA USA

[2] AstraZeneca Neurosci IMed, Cambridge, MA USA

[3] Univ Washington, Dept Chem Engn, Seattle, WA 98195 USA

[4] Univ S Florida, Dept Pharmaceut Sci, Tampa, FL USA

[5] Univ Calif San Diego, Dept Neurosci, Skaggs Sch Pharm, La Jolla, CA 92093 USA

来源：

JOURNAL OF NEUROTRAUMA | 2016年 / 33卷 / 13期

关键词：

cysteine proteases; E64d; E64c;

D O I：

暂无

中图分类号：

R4 [临床医学];

学科分类号：

1002 ; 100602 ;

摘要：

PSA-166

引用

页码：A71 / A72

页数：2

共 29 条

[21] The protease inhibitor E64d might attenuate the development of experimental anti-glomerular basement membrane disease through regulating the activation of Th1 cells
Gu, Qiu-hua
Xu, Hao
Cao, Xin
Cheng, Xi
Jia, Jun-ya
Yan, Tie-kun
INTERNATIONAL IMMUNOPHARMACOLOGY, 2024, 129
[22] Effects of proteasome inhibitor (lactacystin) and cysteine protease inhibitor (E-64-d) on processes of mitosis in Xenopus embryonic cells
Sekiguchi, T
Hosoyama, Y
Miyata, S
ZOOLOGICAL SCIENCE, 2002, 19 (11) : 1251 - 1255
[23] Effects of Cysteine Proteinase Inhibitors scN and E-64 on Southern Corn Rootworm1 Larval Development
Armstrong, J. S.
Camelo, L. A.
Zhu-Salzman, K.
Mitchell, F. L.
SOUTHWESTERN ENTOMOLOGIST, 2016, 41 (02) : 337 - 345
[24] Small Molecule Drug C381 Attenuates Brain Vascular Damage Following Repetitive Mild Traumatic Injury
Li, Lulin
Nguyen, Andy
Zhao, Brian
Vest, Ryan
Yerra, Lakshmi
Sun, Bryan
Luo, Jian
NEUROTRAUMA REPORTS, 2024, 5 (01): : 1016 - 1026
[25] Using Decision Tree Methodology to Predict Employment after Moderate to Severe Traumatic Brain Injury (vol 34, pg E64, 2019)
Stromberg, K. A.
Agyemang, A. A.
Graham, K. M.
JOURNAL OF HEAD TRAUMA REHABILITATION, 2019, 34 (06) : 401 - 401
[26] EFFECT OF N-[N-(L-TRANS-3-CARBOXYOXIRANE-2-CARBONYL)-L-LEUCYL]-3-METHYL-BUTYLAMINE (E64C), A THIOL-PROTEASE INHIBITOR, ON TYROSINE RELEASE FROM SKELETAL-MUSCLE CELLS
KOHAMA, K
MITANI, S
SHIRAO, T
PROCEEDINGS OF THE JAPAN ACADEMY SERIES B-PHYSICAL AND BIOLOGICAL SCIENCES, 1987, 63 (10): : 376 - 380
[27] Inhibition of osteoclast differentiation by the cysteine proteinase inhibitors cystatin C and E-64 is associated with inhibition of RANK, OSCAR, DAP12, NFAT2, MITF and PU.1, but not of c-Fms or FcRγ.
Persson, L.
Lie, A.
Saftig, P.
Grubb, A.
Lerner, U. H.
JOURNAL OF BONE AND MINERAL RESEARCH, 2006, 21 : S160 - S160
[28] Proceedings: Use of imaging in drug R&D William C. Eckelman, PhD and Raymond E. Gibson, PhD, Guest Editors - A Society of Nuclear Imaging in Drug Development (SNIDD) sponsored Symposium - September 11-13, 1998, National Institutes of Health, Bethesda, MD - Abstracts
不详
JOURNAL OF CLINICAL PHARMACOLOGY, 1999, 39 : 56S - 60S
[29] Proceedings: Use of imaging in drug R&D William C. Eckelman, PhD and Raymond E. Gibson, PhD, Guest Editors - A Society of Nuclear Imaging in Drug Development (SNIDD) sponsored symposium - September 11-13, 1998, National Institutes of Health, Bethesda, MD - Introduction
Eckelman, WC
JOURNAL OF CLINICAL PHARMACOLOGY, 1999, 39 : 4S - 5S

← 1 2 3 →